O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+9.02%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$5.37M
AUM Growth
+$5.37M
(-2.2%)
Cap. Flow
-$267K
Cap. Flow
% of AUM
-4.97%
Top 10 Holdings %
Top 10 Hldgs %
30.7%
Holding
153
New
13
Increased
31
Reduced
32
Closed
21
Top Buys
| 1 |
THRD
Third Harmonic Bio
THRD
|
$110K |
| 2 |
Sarepta Therapeutics
SRPT
|
$99.3K |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$50.1K |
| 4 |
Thermo Fisher Scientific
TMO
|
$45K |
| 5 |
BLU
BELLUS Health Inc.
BLU
|
$33.6K |
Top Sells
Sector Composition
| 1 | Healthcare | 98.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SVA
1
DELISTED
Sinovac Biotech, Ltd
SVA
| $341K | 6.32% | 2,718,735 | – | – |
|
2
Bristol-Myers Squibb
BMY
$96B
| $184K | 3.41% | 2,584,900 +66,200 | +3% | +$4.71K |
|
3
Humana
HUM
$36.5B
| $169K | 3.14% | 348,700 -17,000 | -5% | -$8.25K |
|
|
SWTX
4
DELISTED
SpringWorks Therapeutics
SWTX
| $158K | 2.93% | 5,525,926 -502,381 | -8% | -$14.3K |
|
5
Boston Scientific
BSX
$156B
| $151K | 2.8% | 3,898,200 -471,300 | -11% | -$18.3K |
|
6
BioMarin Pharmaceuticals
BMRN
$11.2B
| $146K | 2.7% | 1,717,310 +17,600 | +1% | +$1.49K |
|
7
Edgewise Therapeutics
EWTX
$1.51B
| $143K | 2.66% | 14,567,176 +484,496 | +3% | +$4.77K |
|
8
UnitedHealth
UNH
$281B
| $135K | 2.51% | 267,200 -14,000 | -5% | -$7.07K |
|
9
Pfizer
PFE
$141B
| $114K | 2.11% | 2,599,000 -145,000 | -5% | -$6.35K |
|
|
THRD
10
DELISTED
Third Harmonic Bio
THRD
| $110K | 2.04% | +5,779,071 | New | +$110K |
|
11
Vertex Pharmaceuticals
VRTX
$100B
| $108K | 2.01% | 373,200 -14,000 | -4% | -$4.05K |
|
|
TCDA
12
DELISTED
Tricida, Inc. Common Stock
TCDA
| $108K | 2% | 10,280,947 | – | – |
|
13
Intuitive Surgical
ISRG
$170B
| $107K | 1.99% | 572,700 +55,500 | +11% | +$10.4K |
|
14
Adicet Bio
ACET
$59.9M
| $106K | 1.97% | 7,447,140 -1 | -0% | – |
|
|
SGEN
15
DELISTED
Seagen Inc. Common Stock
SGEN
| $104K | 1.94% | 762,600 +75,100 | +11% | +$10.3K |
|
|
16
Thermo Fisher Scientific
TMO
$186B
| $103K | 1.9% | 202,200 +88,800 | +78% | +$45K |
|
|
17
Sarepta Therapeutics
SRPT
$1.78B
| $102K | 1.88% | 918,500 +898,500 | +4,493% | +$99.3K |
|
|
MRTX
18
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $99.1K | 1.84% | 1,418,892 +328,492 | +30% | +$22.9K |
|
|
THRX
19
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $98.8K | 1.83% | 17,041,668 | – | – |
|
20
Neurocrine Biosciences
NBIX
$13.8B
| $95.2K | 1.77% | 896,545 +47,000 | +6% | +$4.99K |
|
21
argenx
ARGX
$43.6B
| $95.2K | 1.77% | 269,700 +75,700 | +39% | +$26.7K |
|
22
Stryker
SYK
$150B
| $85.7K | 1.59% | 423,100 -18,000 | -4% | -$3.65K |
|
23
AbbVie
ABBV
$372B
| $80.5K | 1.49% | 600,000 -199,800 | -25% | -$26.8K |
|
24
Edwards Lifesciences
EW
$47.8B
| $79.8K | 1.48% | 966,300 -45,000 | -4% | -$3.72K |
|
25
PMV Pharmaceuticals
PMVP
$74.2M
| $78.1K | 1.45% | 6,563,077 | – | – |
|